Medically reviewed by Dr Pinakin V Parekh, Consultant Interventional Cardiologist, Trident Heart Centre Singapore
Your latest blood test comes back and your LDL cholesterol is finally in the normal range. After months or possibly years of taking a daily tablet, it is tempting to wonder: if the numbers look fine, do I still need the medication?
It is one of the most common questions cardiologists hear. And it deserves a straight, thorough answer.
The short answer is: for most people, no. Stopping cholesterol medication when your levels normalise is not recommended, and doing so carries real cardiovascular risk. But the longer answer is more nuanced, and understanding it helps you have a much more informed conversation with your doctor.
Why Your Cholesterol Levels Looked Normal in the First Place
This is the part most patients miss.
When you take a cholesterol-lowering medication, most commonly a statin such as atorvastatin or rosuvastatin, the drug is actively suppressing your liver’s production of LDL cholesterol. The normal reading on your blood test is not evidence that your cholesterol problem has resolved. It is evidence that the medication is doing its job.
Think of it like blood pressure medication. If you take a tablet for high blood pressure and your reading comes back normal, that does not mean your blood pressure is fixed, it means the drug is controlling it. Cholesterol works the same way.
What Happens to Your LDL If You Stop?
Statins lower LDL cholesterol while you are taking them, but they do not necessarily remove the underlying reason your cholesterol is elevated. When treatment is stopped, LDL cholesterol can rise again.
One randomised controlled study followed people with type 2 diabetes who had achieved an LDL-C level below 100 mg/dL on rosuvastatin. After approximately 10 weeks, 79% of those who stopped treatment had their LDL-C rise above 100 mg/dL, compared with just 3% of those who continued taking the statin. In the group whose cholesterol relapsed, LDL-C rose from an average of about 68 mg/dL to 136 mg/dL. (Source: PMC)
This does not mean that everyone who stops a statin will experience the same degree or speed of increase. How much LDL rises depends on factors such as the person’s cholesterol levels before treatment and their underlying cardiovascular risk.
The important point is that a lower cholesterol reading while taking a statin does not necessarily mean the underlying tendency towards high cholesterol has gone away.
The Difference Between “Normal Numbers” and a “Cured Condition”
High cholesterol is not an infection that can be treated and cleared. For the vast majority of patients, it is a chronic, lifelong metabolic tendency driven by genetics, lifestyle, or both.
The medical term for this is polygenic hypercholesterolaemia — a predisposition to produce more LDL than the body can efficiently clear. No medication changes this underlying tendency. What statins do is manage the output, highly effectively, for as long as you take them.
This distinction matters enormously for long-term cardiovascular risk. Every year that LDL remains elevated, even modestly, contributes to the slow accumulation of plaque in the arteries (atherosclerosis). The damage is cumulative and largely silent until a cardiac event occurs.
Understanding Your Personal Cardiovascular Risk
Whether stopping medication is ever appropriate depends heavily on why you were prescribed it in the first place.
Cardiologists evaluate patients using a combination of factors:
- LDL cholesterol level — how high it is and how long it has been elevated
- Age and sex
- Blood pressure
- Smoking status
- Family history of heart disease
- Diabetes status
- Existing cardiovascular disease — whether you have already had a heart attack, stroke, or angioplasty
These factors are combined into a cardiovascular risk score. Patients fall broadly into three groups:
| Risk Category | Example Patient | LDL Target (General) |
| Low risk | Younger adult, no risk factors, mildly elevated LDL | Below 3.0 mmol/L |
| Intermediate risk | Middle-aged, hypertensive, no prior cardiac event | Below 2.6 mmol/L |
| Can they refer each other? | Post-heart attack, diabetes with organ damage, established arterial disease | Below 1.8 mmol/L |
For high-risk patients, particularly those who have already had a cardiac event, statins are not just about lowering cholesterol. Research consistently shows they reduce the risk of a second heart attack, stroke, or cardiac death regardless of baseline LDL. In this group, stopping medication is rarely appropriate even when LDL looks perfectly normal.
When Might a Doctor Consider Stopping or Reducing Cholesterol Medication?
There are legitimate clinical scenarios where a cardiologist might consider deprescribing or reducing a statin. These are the exception, not the rule, and always require careful medical assessment.
Genuinely Low Cardiovascular Risk With Mild Hypercholesterolaemia
If a young, otherwise healthy patient with no family history of heart disease and no other risk factors has mildly elevated cholesterol that responds strongly to a modest statin dose, and is committed to significant dietary and lifestyle changes, a supervised trial period without medication may occasionally be discussed.
Intolerable Side Effects
A small proportion of patients experience significant side effects from statins, most commonly muscle pain (myalgia). In these cases, a doctor might reduce the dose, switch to a different statin, or explore non-statin alternatives, rather than stopping treatment entirely.
End-of-Life or Frailty Considerations
In elderly patients with significant frailty or limited life expectancy, the risk-benefit calculation can shift. In these circumstances, deprescribing may be appropriate as part of a broader conversation about treatment burden.
What About Lowering Cholesterol Through Lifestyle Alone?
Some patients do achieve meaningful LDL reductions through dietary changes and exercise, and this is genuinely worth pursuing. Dietary changes can reduce LDL cholesterol meaningfully, with comprehensive dietary interventions producing average reductions of around 13% to 20% in clinical trials. (Source: NCBI)
For patients with mildly elevated cholesterol and low cardiovascular risk, this may be enough to bring levels into an acceptable range without medication.
However, for patients who were prescribed statins because lifestyle changes alone were insufficient, or whose cardiovascular risk is elevated for other reasons, this approach is unlikely to maintain the LDL levels that medication was achieving.
The Risk of Stopping Without Medical Guidance
Some patients stop their medication independently, because of side effect concerns, cost, inconvenience, or simply because they feel well. This is understandable, but it carries risk.
The most clinically significant concern is what researchers have described as a possible statin withdrawal or rebound effect. Experimental and clinical studies suggest that abruptly stopping statins may cause adverse changes in vascular function and, in some circumstances, may be associated with worse cardiovascular outcomes. This appears to be particularly concerning in people experiencing acute vascular events, although the evidence is less clear in stable patients (Source: PubMed). For this reason, statins should not be stopped abruptly without discussing the decision with your doctor.
If you have concerns about your medication, side effects, cost, whether it is still necessary., the right step is always to raise them with your doctor, not to stop unilaterally.
The Bottom Line
Achieving a normal cholesterol reading on medication is a success, and it means the treatment is working. For most patients, it is not a signal to stop. It is a signal to continue.
The goal of cholesterol management is not just a good number on a blood test. It is reducing the lifetime risk of a heart attack or stroke. That goal does not disappear when the number improves.
If you are unsure whether your cholesterol medication is still appropriate for your situation, the most valuable thing you can do is book a review with a cardiologist who can assess your complete cardiovascular risk profile, not just the number on your latest report.
About Dr Pinakin V Parekh
Dr Pinakin V Parekh is a Consultant Interventional Cardiologist and the founder of Trident Heart Centre, Singapore. He specialises in coronary artery disease, angioplasty, and preventive cardiology. Dr Pinakin has over 20 years of experience treating patients with complex cardiovascular conditions and is committed to helping patients understand, and not just manage their heart health.
